بدائل البحث:
larger decrease » marked decrease (توسيع البحث)
means decrease » mean decrease (توسيع البحث), deaths decreased (توسيع البحث)
large decrease » marked decrease (توسيع البحث), large increases (توسيع البحث), large degree (توسيع البحث)
5 means » _ means (توسيع البحث), k means (توسيع البحث), i means (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
means decrease » mean decrease (توسيع البحث), deaths decreased (توسيع البحث)
large decrease » marked decrease (توسيع البحث), large increases (توسيع البحث), large degree (توسيع البحث)
5 means » _ means (توسيع البحث), k means (توسيع البحث), i means (توسيع البحث)
-
1
<b>Supporting data for manuscript</b> "<b>Voluntary locomotion induces an early and remote hemodynamic decrease in the large cerebral veins</b>"
منشور في 2025"…<p dir="ltr">The CSV file 'Eyreetal_DrainingVein_SourceData' contains the averaged time series traces and extracted metrics from individual experiments used across Figures 1-5 in the manuscript "Voluntary locomotion induces an early and remote hemodynamic decrease in the large cerebral veins". …"
-
2
The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness.
منشور في 2025"…Parameter values: interaction strengths were drawn from a half-normal distribution of zero mean and a standard deviation of 0.2, and strength for consumers was made no larger than the strength for resources. …"
-
3
-
4
-
5
Table 5_Road transportation is associated with decreased intestinal motility in horses.docx
منشور في 2025"…Horses with high heart rates, high sweat scores or abnormal demeanour on arrival demonstrated decreased intestinal motility. Salivary cortisol concentrations increased after transportation (mean difference, 95% CI, for T0 vs T1 was 1.66, 1.09−2.53 nmol/L) and were inversely associated with intestinal motility. …"
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.
منشور في 2025الموضوعات: -
15
Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.
منشور في 2025الموضوعات: -
16
Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.
منشور في 2025الموضوعات: -
17
-
18
-
19
Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.
منشور في 2025الموضوعات: -
20
Baseline patient characteristics across neutralizing monoclonal antibody trials.
منشور في 2025الموضوعات: